TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24597260

Group type: EXPERIMENTAL
Intervention: Patient-controlled lumbar epidural combined anesthesia with Doula using ropivacaine and sufentanil
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group without any analgesic measurements
Number of subjects: 200
Study: 21406193

Group type: EXPERIMENTAL
Intervention: Ubiquinol (100 mg/day)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ubiquinone (100 mg/day)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 18192835

Group type: EXPERIMENTAL
Intervention: Combined consumption of red wine and green olive oil (RO)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combined consumption of red wine and refined olive oil (RG)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combined consumption of white wine and olive oil (WO)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combined consumption of white wine and green olive oil (WG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All four combinations of wine and olive oil
Number of subjects: 15
Study: 16645234

Group type: EXPERIMENTAL
Intervention: Thermostable autologous hemoderivative
Number of subjects: 101

Group type: COMPARATOR
Intervention: Adequate control measures
Number of subjects: 101
Study: 14662586

Group type: EXPERIMENTAL
Intervention: Early treatment with ablation of the avascular retina
Number of subjects: 317

Group type: COMPARATOR
Intervention: Conventional treatment (control eye)
Number of subjects: 317
Study: 10960936

Group type: EXPERIMENTAL
Intervention: Visual feedback training of center‐of‐gravity (CoG) positioning
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Conventional physical therapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Regular therapy (physical therapy and occupational therapy)
Number of subjects: 46
Study: 8792754

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study: 1467105

Group type: EXPERIMENTAL
Intervention: Closed-loop computer control of an infusion of a 5:1 mixture of trimetaphan camsylate (TMP) and sodium nitroprusside (SNP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Manual control by an experienced anaesthetist
Number of subjects: 20
Study: 6086866

Group type: EXPERIMENTAL
Intervention: VZIG (standard doses)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: IGIV at 4 ml/kg every 4 weeks for four doses
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: IGIV at 6 ml/kg every 6 weeks for two to four doses
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: IGIV at 4 ml/kg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: IGIV at 6 ml/kg
Number of subjects: 13

Group type: COMPARATOR
Intervention: VZIG or IGIV
Number of subjects: 13
Study: 30922731

Group type: EXPERIMENTAL
Intervention: Lenvatinib plus pembrolizumab (20 mg oral lenvatinib daily plus 200 mg intravenous pembrolizumab every 3 weeks)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Lenvatinib plus pembrolizumab
Number of subjects: 54
Study: 29351895

Group type: EXPERIMENTAL
Intervention: Partners in Parenting (PiP) program
Number of subjects: 359

Group type: COMPARATOR
Intervention: Standardized package of five Web‐based factsheets about adolescent development and well‐being (active-control)
Number of subjects: 359
Study: 26488145

Group type: EXPERIMENTAL
Intervention: Arthrocentesis group (aspiration before hyaluronan injection)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Nonarthrocentesis group (no aspiration before hyaluronan injection)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Patient and investigator assessment of effectiveness
Number of subjects: 180
Study: 23146963

Group type: EXPERIMENTAL
Intervention: Neural processes associated with stimulus encoding and maintenance in the lateral prefrontal cortex (PFC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neural connectivity between lateral PFC and extrastriate cortex
Number of subjects: 0
Study: 22158146

Group type: EXPERIMENTAL
Intervention: Low-load high-velocity (LLHV = 6 sets of 12 reps at 35% 1RM)
Number of subjects: 12

Group type: COMPARATOR
Intervention: High load-low velocity (HLLV = 3 sets of 12 reps at 70% 1RM)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low-load high-velocity (LLHV)
Number of subjects: 12

Group type: COMPARATOR
Intervention: High load-low velocity (HLLV)
Number of subjects: 12
Study: 20362976

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) based on exposure and mindfulness exercises delivered via the Internet.
Number of subjects: 85

Group type: COMPARATOR
Intervention: Online discussion forum (control condition).
Number of subjects: 85
Study: 18847622

Group type: EXPERIMENTAL
Intervention: School nurse supervision of glucose and insulin-dose adjustment (3-month intervention)
Number of subjects: 36
Study: 16212578

Group type: EXPERIMENTAL
Intervention: sub-antimicrobial doxycycline (20 mg, bid)
Number of subjects: 69

Group type: COMPARATOR
Intervention: placebo control
Number of subjects: 69
Study: 11840077

Group type: EXPERIMENTAL
Intervention: Standard titer (50% tissue culture‐infective dose, 103.8) Schwarz measles vaccine after meningococcal vaccine
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Increased titer (10(4.7) PFU) Edmonston‐Zagreb measles vaccine followed by meningococcal vaccine
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Increased titer (10(4.7) PFU) Connaught vaccine followed by standard titer Schwarz measles vaccine
Number of subjects: 510

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 510
Study: 10405190

Group type: EXPERIMENTAL
Intervention: Early-onset IVH
Number of subjects: 440

Group type: COMPARATOR
Intervention: No early-onset IVH
Number of subjects: 440
Study: 7496419

Group type: EXPERIMENTAL
Intervention: Technique 1 (specific underwear); 3 couples, 42 cycles
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Technique 2 (supplementary ring with specific underwear); 6 couples, 117 cycles
Number of subjects: 9
Study: 1981019

Group type: EXPERIMENTAL
Intervention: Tertatolol 5 mg alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tertatolol 5 mg with rifampicin 600 mg once daily
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tertatolol 5 mg with ranitidine 150 mg twice daily
Number of subjects: 10
Study: 7018306

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31888358

Group type: EXPERIMENTAL
Intervention: Cemented hemiarthroplasty
Number of subjects: 400

Group type: COMPARATOR
Intervention: Uncemented hemiarthroplasty
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 400
Study: 31185906

Group type: EXPERIMENTAL
Intervention: 500 mg oral paracetamol
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: 1000 mg oral paracetamol
Number of subjects: 324

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 324
Study: 29178757

Group type: EXPERIMENTAL
Intervention: White MTA
Number of subjects: 129

Group type: COMPARATOR
Intervention: Formocresol (FC)
Number of subjects: 129
Study: 26194675

Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy (HFRT)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Standard radiation therapy (STRT)
Number of subjects: 137
Study: 23375177

Group type: EXPERIMENTAL
Intervention: Mentoring relationship quality
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Higher quality relationships with parents and teachers
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Effect sizes of associations
Number of subjects: 526
Study: 20708287

Group type: EXPERIMENTAL
Intervention: Indomethacin 75 mg (slow-release)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 19213787

Group type: EXPERIMENTAL
Intervention: Naloxone (10 mg intravenously)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 17
Study: 16824149

Group type: EXPERIMENTAL
Intervention: Basiliximab (20 mg on days 0 and 4)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Daclizumab (50 mg on days 1 and 14)
Number of subjects: 58
Study: 12615254

Group type: EXPERIMENTAL
Intervention: RV infarction
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Severe RV infarction (right atrial pressure ≥ 15 mm Hg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Mild/moderate RV infarction (right atrial pressure < 15 mm Hg)
Number of subjects: 25
Study: 10831476

Group type: EXPERIMENTAL
Intervention: Acute treatment of bipolar I disorder with anxiety symptoms
Number of subjects: 124

Group type: COMPARATOR
Intervention: Acute treatment of bipolar I disorder without anxiety symptoms
Number of subjects: 124
Study: 9118516

Group type: EXPERIMENTAL
Intervention: Prostacyclin (epoprostenol) infusion for 12 weeks in addition to conventional therapy (n = 41)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conventional therapy alone for 12 weeks (n = 40)
Number of subjects: 81
Study: 8472628

Group type: EXPERIMENTAL
Intervention: 1 mg GL‐G injection (intramuscularly)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 1 mg GL‐G injection (intravenously)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 1 mg GL‐G injection
Number of subjects: 38
Study: 3525176

Group type: EXPERIMENTAL
Intervention: Intermediate-dose methotrexate (ID-MTX) and prednisone (PRED)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Vincristine (VCR) and prednisone (PRED)
Number of subjects: 137
Study: 31936495

Group type: EXPERIMENTAL
Intervention: Biophysical therapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 24
Study: 29570546

Group type: EXPERIMENTAL
Intervention: Music Therapy (MT) sessions
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control (standard medical care)
Number of subjects: 163
Study: 26702030

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (5 interviews over 12 months)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 372
Study: 24726166

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with optimal medical therapy
Number of subjects: 2201

Group type: COMPARATOR
Intervention: Optimal medical therapy alone (MED)
Number of subjects: 2201

Group type: EXPERIMENTAL
Intervention: Reinfarction (universal definition)
Number of subjects: 2201

Group type: EXPERIMENTAL
Intervention: Reinfarction (OAT criteria)
Number of subjects: 2201

Group type: EXPERIMENTAL
Intervention: Reinfarction occurring within 6 months
Number of subjects: 2201

Group type: EXPERIMENTAL
Intervention: Reinfarction due to the same IRA and a different epicardial vessel
Number of subjects: 2201
Study: 23276779

Group type: EXPERIMENTAL
Intervention: pioglitazone
Number of subjects: 60

Group type: COMPARATOR
Intervention: metformin
Number of subjects: 60
Study: 20576158

Group type: EXPERIMENTAL
Intervention: Mental Health First Aid training for teachers
Number of subjects: 14

Group type: COMPARATOR
Intervention: Wait-listed control group
Number of subjects: 14
Study: 18753099

Group type: EXPERIMENTAL
Intervention: Levothyroxine treatment (n = 60)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo control (n = 60)
Number of subjects: 120
Study: 16698134

Group type: EXPERIMENTAL
Intervention: EGb 761 (120 mg/day as a single dose)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (vegetable-based)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: EGb 761 (120 mg/day)
Number of subjects: 20
Study: 15133864

Group type: EXPERIMENTAL
Intervention: Olsalazine sodium
Number of subjects: 102

Group type: COMPARATOR
Intervention: SASP
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Heartleaf houttuynia herb
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Kangshuanling
Number of subjects: 102

Group type: COMPARATOR
Intervention: Sulfasalazine
Number of subjects: 102
Study: 11575648

Group type: EXPERIMENTAL
Intervention: ThinPrep Pap Test (TP)
Number of subjects: 1999

Group type: COMPARATOR
Intervention: Conventional Pap Test (CV)
Number of subjects: 1999
Study: 9777477

Group type: EXPERIMENTAL
Intervention: Air scented with peppermint
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unscented air
Number of subjects: 0
Study: 8143832

Group type: EXPERIMENTAL
Intervention: Oral indomethacin, 50 mg t.d.s. for 3 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3284341

Group type: EXPERIMENTAL
Intervention: labetalol
Number of subjects: 105

Group type: COMPARATOR
Intervention: prazosin
Number of subjects: 105
Study: 28480984

Group type: EXPERIMENTAL
Intervention: Intravesical chondroitin sulfate (CS)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Intravesical hyaluronic acid (HA)
Number of subjects: 42
Study: 26609122

Group type: EXPERIMENTAL
Intervention: Trauma-Focused (TF) treatment (8 sessions prolonged exposure or eye movement desensitization)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Waiting List (WL)
Number of subjects: 155
Study: 25623237

Group type: EXPERIMENTAL
Intervention: Dressing removed on the first postoperative day
Number of subjects: 96

Group type: COMPARATOR
Intervention: Dressing removed on the sixth postoperative day
Number of subjects: 96
Study: 24384734

Group type: EXPERIMENTAL
Intervention: Lacidipine
Number of subjects: 315

Group type: COMPARATOR
Intervention: Amlodipine besylate
Number of subjects: 315
Study: 21911136

Group type: EXPERIMENTAL
Intervention: Daclizumab (54 patients, group D) plus cyclosporine (CsA), mycophenolate mofetil and steroids
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Thymoglobulin (55 patients, group T) plus cyclosporine (CsA), mycophenolate mofetil and steroids
Number of subjects: 103

Group type: COMPARATOR
Intervention: CMVi+ group
Number of subjects: 103

Group type: COMPARATOR
Intervention: CMVi‐ group
Number of subjects: 103
Study: 18715238

Group type: EXPERIMENTAL
Intervention: Enhanced web-based behavioral smokeless tobacco cessation intervention
Number of subjects: 402

Group type: COMPARATOR
Intervention: Basic information-only control condition
Number of subjects: 402
Study: 16966688

Group type: EXPERIMENTAL
Intervention: oblimersen sodium plus dacarbazine (1,000 mg/m2)
Number of subjects: 771
Study: 14767414

Group type: EXPERIMENTAL
Intervention: Personalized psychomotor fitness program (PF)
Number of subjects: 141

Group type: COMPARATOR
Intervention: General program of psychomotor therapy (GPMT)
Number of subjects: 141
Study: 11103113

Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine
Number of subjects: 84

Group type: COMPARATOR
Intervention: 0.1% ropivacaine plus 0.0002% fentanyl
Number of subjects: 84
Study: 11517472

Group type: EXPERIMENTAL
Intervention: Semax (12 mg for moderate severity, 18 mg for severe strokes, treatment course of 5 to 10 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 30
Study: 8474482

Group type: EXPERIMENTAL
Intervention: Apomorphine 10 micrograms/kg
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Apomorphine 50 micrograms/kg
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Apomorphine 100 micrograms/kg
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Levodopa therapy after apomorphine test
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Final diagnosis based on clinical evaluation and levodopa response
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 3779035

Group type: EXPERIMENTAL
Intervention: Sucralfate (1 g doses four times a day for 2 days prior to and during the study)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ibuprofen (400 mg single oral dose)
Number of subjects: 12
Study: 31687738

Group type: EXPERIMENTAL
Intervention: Hookah is the Enemy of Health Campaign (HEHC)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 280
Study: 28714788

Group type: EXPERIMENTAL
Intervention: Deep Oscillation Therapy (DOT)
Number of subjects: 29
Study: 28054902

Group type: EXPERIMENTAL
Intervention: Novel goal-directed hemodynamic optimization therapy (GDHOT) based on major vasopressor and inotropic therapy (SG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard goal-directed hemodynamic optimization therapy (GDHOT) (CG)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Novel GDHOT (SG)
Number of subjects: 40
Study: 24953368

Group type: EXPERIMENTAL
Intervention: Tissue-selecting therapy (TST)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Procedure for prolapse and hemorrhoids (PPH)
Number of subjects: 120
Study: 22884437

Group type: EXPERIMENTAL
Intervention: Virtual reality balance games (VRBG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional balance exercises
Number of subjects: 36
Study: 20495932

Group type: EXPERIMENTAL
Intervention: Including group (inclusion of the fracture level)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bridging group (excluding the fracture level)
Number of subjects: 80
Study: 18670858

Group type: EXPERIMENTAL
Intervention: Norcholesterol scintigraphy
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: CT attenuation value
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Chemical-shift MRI suppression index
Number of subjects: 78
Study: 15772862

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Tryptophan balancing amino acid drink (placebo)
Number of subjects: 12
Study: 12960371

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg once a day)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: NCX-4016 (800 mg twice a day)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg twice a day) with aspirin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg twice a day) with NCX-4016
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Aspirin and NCX-4016
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 32
Study: 10096935

Group type: EXPERIMENTAL
Intervention: AV junction ablation and DDDR/MS pacing
Number of subjects: 56

Group type: COMPARATOR
Intervention: DDDR/MS pacing
Number of subjects: 56

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 56
Study: 8694619

Group type: EXPERIMENTAL
Intervention: 10 mg/kg methylprednisolone in the pump prime (group II)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: No steroid (group I)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (group III)
Number of subjects: 24
Study: 1751270

Group type: EXPERIMENTAL
Intervention: Extradural analgesia with continuous infusion of 0.25% bupivacaine with fentanyl
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Extradural analgesia with continuous infusion of 0.25% bupivacaine without fentanyl
Number of subjects: 53

Group type: COMPARATOR
Intervention: Parenteral opioid analgesia
Number of subjects: 53
Study: 6153035

Group type: EXPERIMENTAL
Intervention: Copper-7 (Cu-7) IUD
Number of subjects: 398

Group type: COMPARATOR
Intervention: Copper-T (Cu-T) IUD
Number of subjects: 398
Study: 30425008

Group type: EXPERIMENTAL
Intervention: Clinical medication review (CMR) focused on personal goals using Goal Attainment Scaling (GAS)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Implementation of recommendations for GAS-related drug-related problems (DRPs)
Number of subjects: 315
Study: 29560909

Group type: EXPERIMENTAL
Intervention: Accelerated intermittent theta burst stimulation (aiTBS) treatment, 20 iTBS sessions applied to the left dorsolateral prefrontal cortex (5 daily sessions spread over 4 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham treatment (control group)
Number of subjects: 50
Study: 27333958

Group type: EXPERIMENTAL
Intervention: Aster spathulifolius Maxim extract (700 mg/d of ASE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 25234526

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg and Celecoxib 400 mg (experimental group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lactose powder 2 g (placebo group)
Number of subjects: 0
Study: 21571464

Group type: EXPERIMENTAL
Intervention: Sorbsan(®) (calcium alginate)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Beschitin‐F(®) (chitin‐coated gauze)
Number of subjects: 40
Study: 19384168

Group type: EXPERIMENTAL
Intervention: Low-Tac
Number of subjects: 156

Group type: COMPARATOR
Intervention: Standard-dose CsA
Number of subjects: 156

Group type: COMPARATOR
Intervention: Low dose of CsA
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Patients with serum creatinine ≤ 1.5 mg/mL
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Patients with acute rejection
Number of subjects: 156
Study: 17587625

Group type: EXPERIMENTAL
Intervention: Caudal epidural injection plus therapeutic exercise
Number of subjects: 64

Group type: COMPARATOR
Intervention: NSAIDs plus therapeutic exercise
Number of subjects: 64
Study: 15986724

Group type: EXPERIMENTAL
Intervention: Functional Swallowing Therapy (FST)
Number of subjects: 208
Study: 12147313

Group type: EXPERIMENTAL
Intervention: 1000 IU/h intravenous unfractionated heparin (UFH), n=70
Number of subjects: 167

Group type: COMPARATOR
Intervention: 300 mg oral aspirin, n=97
Number of subjects: 167
Study: 11192234

Group type: EXPERIMENTAL
Intervention: Salmeterol 100 microg b.i.d. for 2 weeks
Number of subjects: 20
Study: 12013486

Group type: COMPARATOR
Intervention: Low-sodium mineral water (sodium, chloride and bicarbonate < 0.02 mmol/l)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate-rich mineral water (sodium 39.3 mmol/l, chloride 6.5 mmol/l, bicarbonate 48.8 mmol/l)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Sodium chloride-rich mineral water (sodium 84.5 mmol/l, chloride 63.7 mmol/l, bicarbonate 21.9 mmol/l)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Low-sodium mineral water
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate-rich mineral water
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Sodium chloride-rich mineral water
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: All regimens
Number of subjects: 21
Study: 1601536

Group type: EXPERIMENTAL
Intervention: Nicotine gum (NG)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Nicotine gum plus psychological treatment (NG-PT)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Nicotine gum plus psychological treatment and partner support (NG-PT-PS)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control (no partner support)
Number of subjects: 99